Download PDF
1 / Pages

Other users also viewed these articles

New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD Louise Torres; Alice Schuch; Larisse Longo; Bruna Bressan Valentini; Gabriela Schneider Galvão; Eduardo Luchese; Carlos Pinzon; Rodrigo Bartels; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28:
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease Juan Pablo Arab; Melisa Dirchwolf; Mário Reis Álvares-da-Silva; Francisco Barrera; Carlos Benítez; Marlene Castellanos-Fernandez; Graciela Castro-Narro; Norberto Chavez-Tapia; Daniela Chiodi; Helma Cotrim; Kenneth Cusi; Claudia Pinto Marques Souza de Oliveira; Javier Díaz; Eduardo Fassio; Solange Gerona; Marcos Girala; Nelia Hernandez; Sebastián Marciano; Walter Masson; Nahum Méndez-Sánchez; Nathalie Leite; Adelina Lozano; Martín Padilla; Arturo Panduro; Raymundo Paraná; Edison Parise; Marlene Perez; Jaime Poniachik; Juan Carlos Restrepo; Andrés Ruf; Marcelo Silva; Martín Tagle; Monica Tapias; Kenia Torres; Eduardo Vilar-Gomez; José Eduardo Costa Gil; Adrian Gadano; Marco Arrese;
Ann Hepatol. 2020;19:674-90
Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening? Diego García-Compeán; Jesús Zacarías Villarreal-Pérez; Manuel Enrique de la O. Cavazos; Fernando Javier Lavalle-Gonzalez; Omar David Borjas-Almaguer; Angel Noé Del Cueto-Aguilera; José Alberto González-González; Consuelo Treviño-Garza; Lourdes Huerta-Pérez; Héctor Jesús Maldonado-Garza;
Ann Hepatol. 2020;19:258-64